AHFS Patient Drug Information | Mobile App & Web

AHFS Patient Drug Information 2023, provides mobile healthcare practitioners with the latest in trusted clinical information for more accurate, confident and informed decision-making at point-of-care.

Includes 1-year online access with WebView.

Editor(s): American Society of Health-System Pharmacists, Inc.

Publisher: American Society of Health-System Pharmacists, Inc.

2023 Edition

Patients need up-to-date information on proper drug usage. When Patients fully understand what's expected of them, they are more likely to get the desired results from their drug therapy. FamilyRx: AHFS Patient Drug Information gives you a single source for providing important information and instructions for patients on dosing, precautions, possible side effects and interactions, and more. FamilyRx: AHFS Patient Drug Information is updated quarterly and includes home infusion and cancer chemotherapy monographs.

Family Rx: AHFS Patient Drug Information contains over 875 drug monographs and includes new and updated black box warnings. Physicians can:
  • Build trust with patients by providing useful, understandable information on their medications.
  • Improve communication and patient compliance.
  • Empower patients to be more active and involved in their treatment.
  • New and updated drug information includes:
    • Pepcid
    • Flonase
    • Paxil
    • Remicade
With FamilyRx: AHFS Patient Drug Information, positive outcomes are achieved because patients understand the benefits and potential dangers of their medications.

With Skyscape's patented smARTlink™ technology, FamilyRx™ can easily cross-index with other titles from Skyscape to provide a powerful and integrated source of clinical information that you can carry with you anytime and anywhere!
{familyrx22:3583}